The GMA and GMOs
·
Written by Ken Fuller
Tuesday,
01 July 2014 00:00
·
Daily Tribune
This column has recently
made mention of the increasingly common practice by which corporations, sometimes
aided by “free trade” agreements, sue governments that take decisions which,
while they might serve the interests of the people of the country concerned,
run counter to those of the corporate bottom line.
Well,
there is now a further example, although the respondent in this case is not a
country but a state: Vermont, the second least
populous state in the USA.
And what is Vermont’s
crime? Earlier this year it passed a law which is not to the liking of
Monsanto, the agriculture giant responsible for much of the world’s genetically
modified organisms (GMOs).
Vermont
has taken the position, which most people would find eminently reasonable, that
if there is no scientific consensus concerning the safety of GMOs (the truth of
the matter is that there have been no studies “proving” their safety apart from
those funded by the corporations that produce them), then the consumer should
at least be alerted to the fact that a product contains them. Products
containing GMOs should, in short, be labeled.
In
mid-June, a suit was filed against Vermont
by a coalition consisting of the Grocery Manufacturers Association (GMA), the
Snack Food Association, the International Dairy Foods Association and the
National Association of Manufacturers. The first-named of these consists of
over 300 of the world’s largest food manufacturers, including Monsanto, which
threatened to sue as long ago as 2012, causing Vermont legislators to place the labeling
measure on hold.
Monsanto
is notoriously litigious, having filed almost 150 lawsuits between 1997 and
2010, many against independent farmers who made allegations against its GMO
products.
It
is not, however, that the Grocery Manufacturers Association is against labeling
per se. Far from it, for in December last year the New York Times reported that
the GMA had written to the Food and Drug Administration advising that it would
be petitioning that body to rule that food containing GMOs should be labeled as
“natural.” For the GMA, therefore, labels are okay as long as they lie.
The
GMA argues in this case that the labeling of GMO products would be a “burden”
for industry (a burden that suddenly vanishes, it would seem, if GMOs are
labeled as “natural”), and that Vermont
has usurped the powers of the federal government, which alone has
responsibility for such regulation. The GMA is also promoting a congressional
bill to this latter effect — a useful illustration of the nature of US
“democracy” as recently discussed in this column.
The
impact of this case will extend beyond Vermont,
as several other states have said that they will follow suit — if Vermont survives the
legal challenge. Connecticut
already has a labeling law, but its implementation is conditional upon other
states, with a total population of at least 20 million, enacting similar
legislation. Likewise, implementation of the law in Maine is dependent upon five other states
adopting the measure.
Such
qualifications were inserted, says the Center for Food Safety’s lead attorney,
because these states feared what Vermont
now faces — “getting sued by Monsanto, the GMA, the biotech industry.”
Some
states like Washington and California have already rejected labeling
requirements. Did citizens in those states arrive at their decisions by
exercises in Jeffersonian democracy, attending town meetings where arguments
pro and con were advanced and the issue was soberly debated? Of course not. The
industry giants spent at least $20 million in Washington
state and $46 million in California
to achieve those negative votes.
Some
Filipino columnists have over the past year or so taken the side of the GMO
corporations by presenting the conflict in this country as being one between
“our farmers” and “our scientists” against the “powerful, European” campaigning
organization Greenpeace. The truth, of course, is that Filipino scientists and
farmers were involved in the case against the GMO trials at UP Los Baños,
alongside the Filipino arm of Greenpeace. The foreign interest was represented
by the GMO-producing corporations, often concealed within innocent-sounding
research institutes.
To
present the Filipino case as a David vs Goliath struggle in which Greenpeace
takes the latter role is a ludicrous misrepresentation of the facts. The
corporate interest plays the role of the giant in both the Philippines and Vermont, and in the latter case this is as
clear as it can possibly be.
Vermont’s population in 2013 was 626,630, its total revenue $1.732 billion. Monsanto’s net sales in 2011 came to $11.82 billion. And that’s just Monsanto. Its power in this case is augmented by that of the other 300 members of the GMA (to name just a few: Dow, Mars, Kellogg, Proctor & Gamble, Hershey, Pepsico, Coca-Cola, Heinz, Unilever, Kraft, Campbell Soup) and those of the other three members of the coalition.
Vermont’s population in 2013 was 626,630, its total revenue $1.732 billion. Monsanto’s net sales in 2011 came to $11.82 billion. And that’s just Monsanto. Its power in this case is augmented by that of the other 300 members of the GMA (to name just a few: Dow, Mars, Kellogg, Proctor & Gamble, Hershey, Pepsico, Coca-Cola, Heinz, Unilever, Kraft, Campbell Soup) and those of the other three members of the coalition.
Last
December, the Food and Drug Administration announced that there would be no
labeling requirement for GMOs in this country as they were virtually no
different from organic foods and were not cancer-causing, as “numerous tests”
had demonstrated. The Court of Appeals in the Los Baños case took a different
view — as have the 60 countries which have either banned GMOs outright or have
a labeling requirement.
Had
the decision been different (and, of course, it’s still possible for a more
enlightened administration to reverse this one), those who attempt to conceal
the role of corporate interests in the trialing and promotion of GMOs would
have received an education as those interests would have targeted the
Philippines just as they’re targeting Vermont. That being the case, it makes
one wonder whether, considering this possibility, the FDA decided to play the
role of Maine and Connecticut.